Stifel Financial’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,373
| Closed | -$6M | – | 2640 |
|
|
2017
Q1 | $6M | Buy |
2,373
+565
| +31% | +$1.43M | 0.02% | 631 |
|
|
2016
Q4 | $4.11M | Buy |
1,808
+126
| +7% | +$286K | 0.02% | 732 |
|
|
2016
Q3 | $4.23M | Buy |
1,682
+360
| +27% | +$905K | 0.02% | 696 |
|
|
2016
Q2 | $4.05M | Buy |
1,322
+71
| +6% | +$217K | 0.02% | 698 |
|
|
2016
Q1 | $3.97M | Buy |
1,251
+231
| +23% | +$733K | 0.02% | 635 |
|
|
2015
Q4 | $5.23M | Buy |
1,020
+132
| +15% | +$677K | 0.03% | 546 |
|
|
2015
Q3 | $2.82M | Buy |
888
+309
| +53% | +$982K | 0.02% | 769 |
|
|
2015
Q2 | $2.31M | Buy |
579
+57
| +11% | +$228K | 0.01% | 921 |
|
|
2015
Q1 | $2.08M | Sell |
522
-2
| -0.4% | -$7.99K | 0.01% | 924 |
|
|
2014
Q4 | $2.57M | Buy |
524
+58
| +12% | +$285K | 0.01% | 800 |
|
|
2014
Q3 | $1.89M | Buy |
466
+51
| +12% | +$207K | 0.02% | 784 |
|
|
2014
Q2 | $1.68M | Buy |
415
+28
| +7% | +$113K | 0.02% | 848 |
|
|
2014
Q1 | $1.76M | Buy |
+387
| New | +$1.76M | 0.02% | 794 |
|